These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 19679843

  • 1. Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis.
    Kramer A, Fletcher J.
    Stroke; 2009 Oct; 40(10):3403-6. PubMed ID: 19679843
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials.
    Ma J, Huang S, Ma L, Liu Y, Li H, You C.
    Crit Care; 2012 Oct 18; 16(5):R198. PubMed ID: 23078672
    [Abstract] [Full Text] [Related]

  • 6. Effect of endothelin receptor antagonists on clinically relevant outcomes after experimental subarachnoid hemorrhage: a systematic review and meta-analysis.
    Laban KG, Vergouwen MD, Dijkhuizen RM, Sena ES, Macleod MR, Rinkel GJ, van der Worp HB.
    J Cereb Blood Flow Metab; 2015 Jul 18; 35(7):1085-9. PubMed ID: 25944590
    [Abstract] [Full Text] [Related]

  • 7. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.
    J Neurosurg; 2016 Jan 18; 124(1):51-8. PubMed ID: 26162034
    [Abstract] [Full Text] [Related]

  • 8. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N, Naraoka M, Ohkuma H, Shimamura N, Ito K, Asano K, Hasegawa S, Takemura A.
    Cerebrovasc Dis; 2016 Jan 18; 42(1-2):97-105. PubMed ID: 27070952
    [Abstract] [Full Text] [Related]

  • 9. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis.
    Sillberg VA, Wells GA, Perry JJ.
    Stroke; 2008 Sep 18; 39(9):2622-6. PubMed ID: 18658040
    [Abstract] [Full Text] [Related]

  • 10. Endothelin receptor antagonists for subarachnoid hemorrhage.
    Guo J, Shi Z, Yang K, Tian JH, Jiang L.
    Cochrane Database Syst Rev; 2012 Sep 12; 2012(9):CD008354. PubMed ID: 22972119
    [Abstract] [Full Text] [Related]

  • 11. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature.
    Velat GJ, Kimball MM, Mocco JD, Hoh BL.
    World Neurosurg; 2011 Nov 12; 76(5):446-54. PubMed ID: 22152574
    [Abstract] [Full Text] [Related]

  • 12. Effect of endothelin-receptor antagonists on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage remains unclear.
    Vergouwen MD.
    Stroke; 2009 Dec 12; 40(12):e714; author reply e715-6. PubMed ID: 19875735
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Shaw MD, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM.
    J Neurosurg; 2000 Dec 12; 93(6):992-7. PubMed ID: 11117873
    [Abstract] [Full Text] [Related]

  • 14. Dose-related effect of statins in patients with endovascular coiling or microsurgical clipping for aneurysmal subarachnoid hemorrhage: updated study-level meta-analysis.
    Choi KS, Kim JM, Yi HJ, Lee SH, Lim T, Kim W, Cho Y, Cheong JH.
    Eur J Clin Pharmacol; 2017 Sep 12; 73(9):1071-1081. PubMed ID: 28293714
    [Abstract] [Full Text] [Related]

  • 15. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
    Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB.
    Stroke; 2010 Jan 12; 41(1):e47-52. PubMed ID: 19875741
    [Abstract] [Full Text] [Related]

  • 16. Microvasospasms After Experimental Subarachnoid Hemorrhage Do Not Depend on Endothelin A Receptors.
    Liu H, Dienel A, Schöller K, Schwarzmaier SM, Nehrkorn K, Plesnila N, Terpolilli NA.
    Stroke; 2018 Mar 12; 49(3):693-699. PubMed ID: 29438081
    [Abstract] [Full Text] [Related]

  • 17. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A, CONSCIOUS-1 Investigators.
    Stroke; 2008 Nov 12; 39(11):3015-21. PubMed ID: 18688013
    [Abstract] [Full Text] [Related]

  • 18. Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage.
    Munakata A, Ohkuma H, Nakano T, Shimamura N, Asano K, Naraoka M.
    Neurosurgery; 2009 Mar 12; 64(3):423-8; discussion 428-9. PubMed ID: 19240603
    [Abstract] [Full Text] [Related]

  • 19. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T.
    Cerebrovasc Dis; 2017 Mar 12; 44(1-2):59-67. PubMed ID: 28463833
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage.
    Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL.
    Stroke; 2007 Aug 12; 38(8):2315-21. PubMed ID: 17569871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.